Efficacy and safety of crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC).
Sai-Hong Ignatius Ou
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
Yung-Jue Bang
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
D. Ross Camidge
Consultant or Advisory Role - Pfizer
Gregory J. Riely
Consultant or Advisory Role - Abbott Laboratories; ARIAD; AstraZeneca; Boehringer Ingelheim; Celgene; Chugai Pharma; Daiichi Sankyo; Foundation Medicine; Novartis; Tragara Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Concordia Pharmaceuticals; GlaxoSmithKline; Infinity; Merck; Novartis; Pfizer
Ravi Salgia
No relevant relationships to disclose
Geoffrey Shapiro
Research Funding - Pfizer
Benjamin J. Solomon
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Jeffrey A. Engelman
Consultant or Advisory Role - Agios; ARIAD; AstraZeneca; Biogen Idec; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Endo Pharmaceuticals; GATEKEEPER Pharmaceuticals; Genentech; GlaxoSmithKline; Novartis; Sanofi
Stock Ownership - Agios
Honoraria - Amgen
Research Funding - AstraZeneca; GlaxoSmithKline; Novartis
Other Remuneration - Abbott Laboratories; Intellikine; Merck; Merrimack
Eunice Lee Kwak
Honoraria - Pfizer
Research Funding - Pfizer
Other Remuneration - Pfizer
Jeffrey W. Clark
Research Funding - Pfizer
Lesley Tye
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Keith D. Wilner
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Patricia Stephenson
No relevant relationships to disclose
Marileila Varella-Garcia
Honoraria - Abbott Molecular
Research Funding - Abbott Molecular
Kristin Bergethon
No relevant relationships to disclose
Anthony John Iafrate
Consultant or Advisory Role - Pfizer
Alice Tsang Shaw
Consultant or Advisory Role - Pfizer